Infinity Pharmaceuticals Story Overview

INFI -- USA Stock  

USD 2.03  0.01  0.49%

Macroaxis does not monitor all media channels or aggregates social signals for Infinity Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Infinity Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Infinity Pharmaceuticals. Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance.
Infinity Pharmaceuticals and Bristol-Myers Squibb Expand Clinical ...
PR Newswire - Sep 25, 2017 CAMBRIDGE, Mass., Sept. 25, 2017 PRNewswire -- Infinity Pharmaceuticals, Inc. today announced that it has expanded its existing clinical collaboration with Bristol-Myers Squibb evaluating IPI-549 in combination with Opdivo to include ...

Read More...   

Story Momentum

This media report from www.prnewswire.com distributed on September 25, 2017 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 3.31% . The trading delta at closing time when the story was published against the current closing price is 68.60% .

Similar stores for Infinity Pharmaceuticals

Analysts See 0.50 EPS for ManTech International Infinity Pharmaceuticals Sentiment Is 1.32news
The Cardinal Weekly 34 Biggest Movers From Friday BenzingaFull coverage
Average True Range under Consideration Cosan Limited , Infinity Pharmaceuticals, Inc ...news
Stocks News Point Full coverage
over a week ago at http://www.thecoinguild.com 
Investors Taking Another Look at Infinity Pharmaceuticals, Inc. After Recent Moves in the Market
news
The Coin GuildInfinity Pharmaceuticals Inc Institutional Investor Sentiment Analysis MoneyMakingArticlesInstitutional Investors Are Betting On Infinity Pharmaceuticals Inc Thorold NewsFull coverage
over a week ago at www.macroaxis.com 
Acquisition by Anthony Evnin of 10000 shares of Infinity Pharmaceuticals subject to Rule 16b-3
Macroaxis News
Filed transaction by Infinity Pharmaceuticals director. Grant, award or other acquisition pursuant to Rule 16b-3
over two weeks ago at http://cnafinance.com 
Infinity Pharmaceuticals Stock Headed Up On Collaboration News
news
CNA FinanceArcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple ... Markets InsiderArcus Biosciences and Infinity Announce Clinical Collaboration to Evaluate Lead Programs in Triple ... StreetInsider.comFull coverage
over three weeks ago at www.macroaxis.com 
Purchase by Bvf Partners L P of 36825 shares of Infinity Pharmaceuticals
Macroaxis News
Filed transaction by Infinity Pharmaceuticals executive. General open market or private purchase of non-derivative or derivative security
over three weeks ago at http://www.stocksnewspoint.com 
Hair-Raising Facts to Know about Companys 50 days simple moving average Arrowhead Pharmaceuticals ...
news
Stocks News Point SEC FORM 4 - SEC.gov SEC.govFull coverage
over a month ago at http://www.streetobserver.com 
Analysts said to Buy Healthcare Stock Infinity Pharmaceuticals, Inc.
news
Street Observer Full coverage
over a month ago at http://www.thestreetpoint.com 
Staggering Stocks Novavax, Inc. , Infinity Pharmaceuticals, Inc. , Arcus Biosciences ...
Thestreet News
The Stock Street Full coverage
over a month ago at http://www.stocksnewspoint.com 
Relative Strength Index in the Spotlight Infinity Pharmaceuticals, Inc. , Network-1 Technologies ...
news
Stocks News Point Is Buying Infinity Pharmaceuticals Inc Here Good Idea BZ WeeklyIs Infinity Pharmaceuticals Inc s Fuel Running High Reports Show Less Sellers Gldmn Blg Full coverage
over two months ago at http://www.stocksnewspoint.com 
Return on Equity to Watch Infinity Pharmaceuticals, Inc. , Axsome Therapeutics, Inc. NASDAQ ...
news
Stocks News Point Full coverage
over three months ago at http://thewellesleysnews.com 
Analyst Research and Ratings Entravision Communications Corporation , Infinity Pharmaceuticals, Inc.
news
Analyst JournalFull coverage
over three months ago at www.macroaxis.com 
Infinity Pharmaceuticals exotic insider transaction detected
Macroaxis News
Filed transaction by Infinity Pharmaceuticals officer. Unconventional Insider trading

Cash Flow from Operations

Cash Flow from Operations Comparative Analysis
  Cash Flow from Operations 
      Infinity Pharmaceuticals Comparables 
Infinity Pharmaceuticals is currently under evaluation in cash flow from operations category among related companies. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investor or analyst to check on the quality of a company earnings.

Peers

Infinity Pharmaceuticals Related Equities
DVAX  6.14 %   
0%
100.0%
DOVA  4.97 %   
0%
80.0%
DRNA  4.70 %   
0%
76.0%
ECYT  2.61 %   
0%
42.0%
CO  0.88 %   
0%
14.0%
DNLI  0.36 %   
5.0%
0%
NK  0.96 %   
15.0%
0%
EARS  1.75 %   
28.0%
0%
EDGE  1.9 %   
31.0%
0%
DMPI  5.04 %   
81.0%
0%
Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.